Advertisement

Topics

How this R&D company is transitioning to a pure-play CDMO: ‘Opportunities are almost endless’

10:39 EST 15 Nov 2017 | Outsourcing-Pharma

Peregrine Pharmaceuticals was a biotech company developing mAbs â now, the company is transitioning to a pure-play contract development and manufacturing organization (CDMO), and expects a âgreat future,â says CEO.

Original Article: How this R&D company is transitioning to a pure-play CDMO: ‘Opportunities are almost endless’

NEXT ARTICLE

More From BioPortfolio on "How this R&D company is transitioning to a pure-play CDMO: ‘Opportunities are almost endless’"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...